// App-Quantinova.ai

: ISG20L2 Suppresses Bortezomib Anti-Myeloma Activity By Attenuating Bortezomib Binding to PSMB5

Researchers

Presenter

  • Yan Yang

Principal Investigators

  • Yuhan Gao

  • Jingcao Huang

  • Ting Niu

  • Yuhuan Zheng

Medical Centers

  • Department of Hematology, West China Hospital, Sichuan Universtiy, Chengdu, China

  • West China Hospital Sichuan University, Chengdu, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • Proteasome Subunit Beta 5

Drug/Treatment

  • carfilzomib Intravenous

  • Bortezomib

  • Interferon

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved